EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access · CC BY 4.0

What Is at Stake in Genetic Newborn Screening for Rare Diseases? An Exploratory Qualitative Study of Parents’ and Expectant Parents’ Concerns in the Screen4Care Project

Sylvia Martin, Åsa Grauman, Joshua Coulter, Mats Hansson, Alessandra Ferlini, Fernanda Fortunato, Silvia Ottombrino, Roman Raming, Ferdinand Knieling, Felix Wachter, Christina Saier, Kathrin Freyler und 1 weitere

Public Health Genomics · 2026

DOI: 10.1159/000553234 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift Public Health Genomics, 2026. Verfasst von Sylvia Martin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Research and Bioethics (CRB), Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Neonatal Screening, Rare Diseases, Genetic Testing, Parents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The diagnostic journey for rare diseases (RDs) often involves lengthy delays and significant burdens on patients and their families. Genetic newborn screening (NBS) for RDs offers a potential opportunity for early diagnosis and treatment. This study explores factors influencing parental decisions regarding participation in genetic NBS for RDs in two European countries (Italy and Germany).

Methods

This mixed-methods qualitative study is composed of focus group discussions and ranking exercises. It was conducted with parents seeking genetic testing (n = 5) and expectant parents from the general population (n = 11). All participants were recruited in spring 2024 in Germany and winter 2024 in Italy via contacts from genetic centres and obstetric services. Thematic analysis was performed by two independent coders to identify main themes and subthemes.

Results

Three key themes were identified: (1) the complexity of the decision-making process, (2) the importance of certainty and disease characteristics, and (3) the anticipation of negative consequences. Participants trusted healthcare professionals to guide their decisions, also emphasizing the need for extensive education and comprehensive support systems. Concerns about test accuracy, potential psychological impact of uncertain or positive results, and anticipated social implications were also reported.

Conclusion

These findings highlight the nuanced considerations surrounding the implementation of genetic NBS for RDs and the necessity of addressing parental experiences in clinical practice and policy development. Participants emphasized the importance of accessible education and clear communication, the support of trusted healthcare professionals and that ethical reflection is essential for the equitable integration of genetic NBS into newborn care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neonatal ScreeningRare DiseasesGenetic TestingParentsHumansInfant, NewbornFemaleQualitative ResearchMaleDecision MakingGermanyItalyAdultFocus Groups

Stichwörter der Autor:innen

Decision-makingGenetic newborn screeningParental preferencesQualitative researchRare diseases

Autor:innen und Institutionen

  • Center for Research and Bioethics (CRB), Uppsala University, Uppsala, Sweden.
  • Pfizer, New York, New York, USA.
  • Unit of Medical Genetics, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
  • Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Department of Pediatrics and Adolescent Medicine, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.
  • Department of Neuropediatrics and Muscle Disorders, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.

Zitieren

APA

Martin, S., Grauman, Å., Coulter, J., Hansson, M., Ferlini, A., Fortunato, F., Ottombrino, S., Raming, R., Knieling, F., Wachter, F., Saier, C., Freyler, K., & Veldwijk, J. (2026). What Is at Stake in Genetic Newborn Screening for Rare Diseases? An Exploratory Qualitative Study of Parents’ and Expectant Parents’ Concerns in the Screen4Care Project. Public Health Genomics. https://doi.org/10.1159/000553234

Vancouver

Martin S, Grauman Å, Coulter J, Hansson M, Ferlini A, Fortunato F, et al. What Is at Stake in Genetic Newborn Screening for Rare Diseases? An Exploratory Qualitative Study of Parents’ and Expectant Parents’ Concerns in the Screen4Care Project. Public Health Genomics. 2026. doi:10.1159/000553234

BibTeX
@article{Martin2026,
  author = {Martin, Sylvia and Grauman, Åsa and Coulter, Joshua and Hansson, Mats and Ferlini, Alessandra and Fortunato, Fernanda and Ottombrino, Silvia and Raming, Roman and Knieling, Ferdinand and Wachter, Felix and Saier, Christina and Freyler, Kathrin and Veldwijk, Jorien},
  title = {What Is at Stake in Genetic Newborn Screening for Rare Diseases? An Exploratory Qualitative Study of Parents’ and Expectant Parents’ Concerns in the Screen4Care Project},
  journal = {Public Health Genomics},
  year = {2026},
  doi = {10.1159/000553234}
}
Kostenlos starten →